Kidney Disease - PACE-CME

Episodes 17-23 of 23

MinuteCE®
Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care
1.25 credits 10 episodes
- Pardeep Jhund, MD, PhD
- Hiddo L. Heerspink, PhD
- John McMurray, MD
- Akshay S. Desai, MD
- Csaba P. Kovesdy, MD
- Finnian R. Mc Causland, MD
- Orly Vardeny, MD
- Muthiah Vaduganathan, MD, MPH
1.25 credits 10 episodes
Nonsteroidal MRAs: The CKD/T1D Potential
Nonsteroidal MRAs: The CKD/T1D Potential
MinuteCE®
Nonsteroidal MRAs: The CKD/T1D Potential
1.25 program credits
- John McMurray, MD
- Hiddo L. Heerspink, PhD
1.25 program credits
Primary care role in CKD
Primary care role in CKD
MinuteCE®
Primary care role in CKD
1.00 program credit
- Richard Hobbs, MD
1.00 program credit
A call to action: optimizing treatment in CKD
A call to action: optimizing treatment in CKD
MinuteCE®
A call to action: optimizing treatment in CKD
1.00 program credit
- Meg Jardine, MD, PhD
1.00 program credit
MinuteCE®
4 things to know about CKD and SGLT2i
1.00 credit 4 episodes
- Hiddo L. Heerspink, PhD
- David Wheeler, MB, CHB, MD, FRCP
- Meg Jardine, MD, PhD
- Richard Hobbs, MD
1.00 credit 4 episodes
When and how to initiate SGLT2i in CKD
When and how to initiate SGLT2i in CKD
MinuteCE®
When and how to initiate SGLT2i in CKD
1.00 program credit
- David Wheeler, MB, CHB, MD, FRCP
1.00 program credit
What is the evidence of SGLT2i in CKD?
What is the evidence of SGLT2i in CKD?
MinuteCE®
What is the evidence of SGLT2i in CKD?
1.00 program credit
- Hiddo L. Heerspink, PhD
1.00 program credit

Previous
1
2
Next

2/2